A large body of evidence generated in the last two and a half years addresses the roles of T
cells in SARS-CoV-2 infection and following vaccination. Infection or vaccination induces …

Infection is the second leading cause of death in patients with chronic kidney disease (CKD).
Adequate humoral (antibody) and cellular (T cell-driven) immunity are required to minimize …

Introduction COVID-19 vaccines have been highly effective in reducing morbidity and
mortality during the pandemic. While primary series vaccination rates are generally high in …

Neutralizing antibodies are considered a correlate of protection against SARS-CoV-2
infection and severe COVID-19, although they are not the only contributing factor to …

As virus outbreaks continue to pose a challenge, a nonspecific viral inhibitor can provide
significant benefits, especially against respiratory viruses. Polyglycerol sulfates recently …

Background Breakthrough SARS-CoV-2 infections in vaccinated individuals have been
previously associated with suboptimal humoral immunity. However, less is known about …

Emerging variants of concern (VOC) raise obstacles in shaping vaccination strategies and
ending the pandemic. Vaccinated SARS-CoV-2 convalescence shapes the current immune …

The role of adaptive SARS-CoV-2 specific immunity in post-acute sequelae of COVID-19
(PASC) is not well explored, although a growing population of convalescent COVID-19 …

Little is known about the effect of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2 or SARS2) vaccine breakthrough infections (BTIs) on the magnitude and breadth of …

Vulnerable patients such as immunosuppressed or elderly patients are at high risk for a
severe course of COVID-19 upon SARS-CoV-2 infection. Immunotherapy with SARS-CoV-2 …